Collaborating for Excellence, Strengthening Clinical Trials in Pakistan - Editorial Commentary
DOI:
https://doi.org/10.69926/pklijhs.68Keywords:
Clinical Trials as Topic, Patient Participation, Government Regulation, Organizational Capacity, Interinstitutional RelationsAbstract
Pakistan, the world’s fifth most populous country, has immense clinical research potential given its diverse population and high disease burden, particularly in endocrinology, neurology and cardiology. Progress, however, is constrained by inconsistent ethical review, weak infrastructure, and limited resources. Strengthening clinical trials requires training, strong governance, incentives for faculty, industry partnerships, and patient and public involvement. In July 2025, Pakistan Kidney and Liver Institute and Research Center hosted a national seminar to explore cross-collaboration and capacity building. The seminar’s overarching goal was to highlight the importance of cross-collaboration and explore opportunities to enhance trial governance and capacity building. It aimed to coalesce discussions into a consensus statement that could guide national strategies for the ethical and efficient conduct of clinical trials in Pakistan.
References
1. Sherin A. Clinical research in Pakistan: past, present and future prospects. Khyber Med Univ J. 2023 Mar 31;15(1):1–3. doi:10.35845/kmuj.2023.23355.
2. Jager W. The importance of clinical trials in advancing medical research. Ann Clin Trials Vaccines Res. 2023;13(3):93–8. doi: 10.37532/ ACTVR.2023.13(3).93-98
3. Kandi V, Vadakedath S. Clinical trials and clinical research: a comprehensive review. Cureus. 2023 Feb 16;15(2). doi: 10.7759/cureus.35077
4. Fountzilas E, Tsimberidou AM, Vo HH, Kurzrock R. Clinical trial design in the era of precision medicine. Genome Med. 2022 Aug 31;14(1):101 doi: 10.1186/s13073-022-01102-1
5. Cortegiani A, Absalom AR. Importance of proper conduct of clinical trials. Br J Anaesth. 2021 Feb;126(2):354–6. doi: 10.1016/j.bja.2020.09.030.
6. Hackshaw A. A concise guide to clinical trials. John Wiley & Sons; 2024 Jun 10.
7. Audisio K, Lia H, Robinson NB, Rahouma M, Soletti G Jr, Cancelli G, Perezgrovas Olaria R, Chadow D, Tam DY, Vervoort D, Farkouh ME. Impact of the COVID-19 pandemic on non-COVID-19 clinical trials. J Cardiovasc Dev Dis. 2022 Jan 10;9(1):19. doi:10.3390/jcdd9010019.
8. Pakistan Clinical Research Landscape Report (Version 1). BMY Health & APPNA-MERIT; 2024 Feb. Available from: https://bmyhealth.com/wp-content/uploads/2024/02/Pakistan-Clinical-Research-Landscape-Report-for-version1.pdf
9. Mumtaz H, Haider SM, Neha F, Saqib M, Nadeem A, Seikha Z. Clinical trials landscape in a lower-middle-income country (Pakistan). J Clin Transl Sci. 2023 Dec 10;8(1):e7. doi:10.1017/cts.2023.701. Erratum in: J Clin Transl Sci. 2024 Feb 22;8(1):e35. doi:10.1017/cts.2024.22.
10. Hayat B, Mumtaz N, Choudry S, Khan MA, Butt AI, Chaudry ZA, Hussain M. Managing Clinical Trials Amid Healthcare Policy Reforms: Challenges and Opportunities. Pak J Health Sci. 2024 Nov 30:304–12. doi: 10.54393/pjhs.v5i11.2402
11. WHO. Pakistan [online feature story]. 2024. Available from: https://www.who.int/news-room/feature-stories/detail/pakistan
12. Moorthy V, Karam G, Karunakara U, Rottingen JA, Savulescu J, White NJ, et al. The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum. Lancet. 2024;403(10422):124–6. doi: 10.1016/S0140-6736(23)02798-8.
13. Fazal A. Ethical issues in conducting cross-cultural research in low-income countries: a Pakistani perspective. Asian Bioeth Rev. 2022 Apr;14(2):151–68. doi: 10.1007/s41649-021-00196-w.
14. Jafree SR, Zakar R, Fischer F. Ethical challenges of conducting clinical trials in Pakistan. J Pharm Policy Pract. 2019;12:29. doi:10.1186/s40545-019-0184-z.
15. Rathore FA, Farooq F. Research Integrity, Governance, and Misconduct in Pakistan: Some Proposed Solutions. JCPSP. 2023 Nov 1;33(11):1338–9.doi:10.29271/jcpsp.2023.11.1338.
16. Tolppa T, Hussaini A, Ahmed N, Dondorp AM, Farooq S, Khan M, Masood A, Murthy S, Saleem S, Shuja Z, Zaman S. Establishment of a patient and public involvement and engagement group to support clinical trials in Pakistan: Initial lessons learned. Res Involv Engagem. 2024 Sep 27;10(1):98. doi: 10.1186/s40900-024-00635-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sadia Hassan, Saeed Hamid, Zeba Aziz, Arishay Hussaini, Javed Akram, Irfan Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PKLI-JHS adopts the CC BY 4.0 license (Creative Commons Attribution 4.0 International License). For specifics, please refer to the full license legal code. The journal utilizes a non-exclusive licensing agreement for open access publishing, allowing authors to retain copyright and primary scholarly usage rights while granting the journal publication and distribution rights.
